Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

766
Chapter | 25 Tumor Markers
1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia
. Endocrinology 131 , 1157 – 1164 .
Rosol , T. J. , Steinmeyer , C. L. , McCauley , L. K. , Grone , A. , DeWille , J. W. ,
and Capen , C. C. ( 1995 ). Sequences of the cDNAs encoding canine
parathyroid hormone-related protein and parathyroid hormone . Gene
160 , 241 – 243 .
Sako , T. , Uchida , E. , Okamoto , M. , Yamamoto , E. , Kagawa , Y. , Yoshino ,
T. , Hirayama , K. , and Taniyama , H. ( 2003 ). Immunohistochemical
evaluation of a malignant intestinal carcinoid in a dog . Vet. Pathol.
40 , 212 – 215 .
Sako , T. , Shimoyama , Y. , Akihara , Y. , Ohmachi , T. , Yamashita , K. ,
Kadosawa , T. , Nakade , T. , Uchida , E. , Okamoto , M. , Hirayama , K. ,
and Taniyama , H. ( 2005 ). Neuroendocrine carcinoma in the nasal
cavity of ten dogs . J. Comp. Pathol. 133 , 155 – 163 .
Sarli , G. , Benazzi , C. , Preziosi , R. , Della Salda , L. , Bettini , G. , and
Marcato , P. S. ( 1999 ). Evaluating mitotic activity in canine and feline
solid tumors: standardizing the parameter . Biotech. Histochem. 74 ,
64 – 76 .
Sarli , G. , Preziosi , R. , Benazzi , C. , Bazzo , R. , Mandrioli , L. , and
Marcato , P. S. ( 2003 ). Rate of apoptosis in feline mammary tumors
is not predictive of postsurgical survival . J. Vet. Diagn. Invest. 15 ,
115 – 122 .
Sarli , G. , Preziosi , R. , Benazzi , C. , Castellani , G. , and Marcato , P. S.
(2002 ). Prognostic value of histologic stage and proliferative activity in
canine malignant mammary tumors . J. Vet. Diagn. Invest. 14 , 25 – 34 .
Sato , T. , Aoki , K. , Shibuya , H. , Machida , T. , and Watari , T. ( 2003 ).
Leiomyosarcoma of the kidney in a dog . J. Vet. Med. A Physiol.
Pathol. Clin. Med. 50 , 366 – 369 .
Scarlett , J. M. (1994 ). Epidemiology of thyroid diseases of dogs and cats .
Vet. Clin. North Am. Small. Anim. Pract. 24 , 477 – 486 .
Scase , T. J. , Edwards , D. , Miller , J. , Henley , W. , Smith , K. , Blunden , A. ,
and Murphy , S. (2006 ). Canine mast cell tumors: correlation of apoptosis
and proliferation markers with prognosis . J. Vet. Intern. Med.
20 , 151 – 158 .
Schwyn , U. , Crompton , N. E. , Blattmann , H. , Hauser , B. , Klink , B. ,
Parvis , A. , Ruslander , D. , and Kaser-Hotz , B. ( 1998 ). Potential
tumour doubling time: determination of Tpot for various canine and
feline tumours . Vet. Res. Commun. 22 , 233 – 247 .
Shirit , D. , Zingerman , B. , Shirit , A. B. , Shlomi , D. , and Kramer , M. R.
( 2005 ). Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3,
and CA 125 assays in pleural effusions: analysis of 116 cases and
review of the literature . Oncologist 10 , 501 – 507 .
Simoes , J. P. , Schoning , P. , and Butine , M. ( 1994 ). Prognosis of canine
mast cell tumors: a comparison of three methods . Vet. Pathol. 31 ,
637 – 647 .
Spangler , W. L. , and Kass , P. H. ( 2006 ). The histologic and epidemiologic
bases for prognostic considerations in canine melanocytic neoplasia .
Vet. Pathol. 43 , 136 – 149 .
Stabenfeldt , G. H. , Hughes , J. P. , Kennedy , P. C. , Meagher , D. M. , and
Neely , D. P. ( 1979 ). Clinical findings, pathological changes and
endocrinological secretory patterns in mares with ovarian tumours .
J. Reprod. Fertil. Suppl. 277 – 285 .
Strefezzi Rde , F. , Xavier , J. G. , and Catao-Dias , J. L. ( 2003 ).
Morphometry of canine cutaneous mast cell tumors . Vet. Pathol. 40 ,
268 – 275 .
Sueiro , F. A. , Alessi , A. C. , and Vassallo , J. (2004 ). Canine lymphomas: a
morphological and immunohistochemical study of 55 cases, with observations
on p53 immunoexpression . J. Comp. Pathol. 131 , 207 –213 .
Tecles , F. , Spiranelli , E. , Bonfanti , U. , Ceron , J. J. , and Paltrinieri , S. (2005 ).
Preliminary studies of serum acute-phase protein concentrations
in hematologic and neoplastic diseases of the dog . J. Vet. Intern. Med.
19 , 865 – 870 .
Teske , E. , Rutteman , G. R. , Kuipers-Dijkshoorn , N. J. , van Dierendonck , J. H. ,
van Heerde , P. , and Cornelisse , C. J. (1993 ). DNA ploidy and cell
kinetic characteristics in canine non-Hodgkin’s lymphoma . Exp.
Hematol. 21 , 579 –584 .
Teske , E. , van Heerde , P. , Rutteman , G. R. , Kurzman , I. D. , Moore , P. F. ,
and MacEwen , E. G. ( 1994 ). Prognostic factors for treatment
of malignant lymphoma in dogs . J. Am. Vet. Med. Assoc. 205 ,
1722 – 1728 .
Theon , A. P. , Lecouteur , R. A. , Carr , E. A. , and Griffey , S. M. ( 2000 ).
Influence of tumor cell proliferation and sex-hormone receptors on
effectiveness of radiation therapy for dogs with incompletely resected
meningiomas . J. Am. Vet. Med. Assoc. 216 , 684 – 685 , 701–707 .
Thomas , R. , Fiegler , H. , Ostrander , E. A. , Galibert , F. , Carter , N. P. , and
Breen , M. ( 2003 ). A canine cancer-gene microarray for CGH analysis
of tumors . Cytogenet. Genome Res. 102 , 254 – 260 .
Thomas , R. , Scott , A. , Langford , C. F. , Fosmire , S. P. , Jubala , C. M. ,
Lorentzen , T. D. , Hitte , C. , Karlsson , E. K. , Kirkness , E. ,
Ostrander , E. A. , Galibert , F. , Lindblad-Toh , K. , Modiano , J. F. ,
and Breen , M. ( 2005 ). Construction of a 2-Mb resolution BAC
microarray for CGH analysis of canine tumors . Genome Res. 15 ,
1831 – 1837 .
Thougaard , A. V. , Hellmen , E. , and Jensen , A. L. ( 1998 ). Total serum
sialic acid is a general disease marker rather than a specific tumour
marker in dogs . Zentralbl. Veterinarmed. A 45 , 471 – 479 .
“ Users ’ Guide to the Medical Literature: A Manual for Evidence-Based
Clinical Practice. ” (2002). AMA Press, Chicago.
Vail , D. M. , Kisseberth , W. C. , Obradovich , J. E. , Moore , F. M. ,
London , C. A. , MacEwen , E. G. , and Ritter , M. A. ( 1996 ).
Assessment of potential doubling time (Tpot), argyrophilic nucleolar
organizer regions (AgNOR), and proliferating cell nuclear antigen
(PCNA) as predictors of therapy response in canine non-Hodgkin’s
lymphoma . Exp. Hematol. 24 , 807 – 815 .
Vail , D. M. , Moore , A. S. , Ogilvie , G. K. , and Volk , L. M. ( 1998 ). Feline
lymphoma (145 cases): proliferation indices, cluster of differentiation
3 immunoreactivity, and their association with prognosis in 90 cats .
J. Vet. Intern. Med. 12 , 349 – 354 .
van der Kolk , J. H. , Wensing , T. , Kalsbeek , H. C. , and Breukink , H. J.
( 1995 ). Laboratory diagnosis of equine pituitary pars intermedia adenoma
. Domest. Anim. Endocrinol. 12 , 35 – 39 .
Veeramani , S. , Yuan , T. C. , Chen , S. J. , Lin , F. F. , Petersen , J. E. ,
Shaheduzzaman , S. , Srivastava , S. , MacDonald , R. G. , and Lin , M. F.
( 2005 ). Cellular prostatic acid phosphatase: a protein tyrosine phosphatase
involved in androgen-independent proliferation of prostate
cancer . Endocr. Relat. Cancer 12 , 805 – 822 .
Vernau , W. , Jacobs , R. M. , Valli , V. E. , and Heeney , J. L. ( 1997 ). The
immunophenotypic characterization of bovine lymphomas . Vet.
Pathol. 34 , 222 – 225 .
Verschueren , C. P. , Selman , P. J. , Mol , J. A. , Vos , J. H. , van Dijk , J. E. ,
Sjollema , B. E. , and de Vijlder , J. J. (1991 ). Circulating thyroglobulin
measurements by homologous radioimmunoassay in dogs with thyroid
carcinoma . Acta Endocrinol. (Copenh.) 125 , 291 – 298 .
von Euler , H. , Einarsson , R. , Olsson , U. , Lagerstedt , A. S. , and Eriksson , S.
( 2004 ). Serum thymidine kinase activity in dogs with malignant lymphoma:
a potent marker for prognosis and monitoring the disease .
J. Vet. Intern. Med. 18 , 696 – 702 .
von Euler , H. P. , Ohrvik , A. B. , and Eriksson , S. K. ( 2006 ). A nonradiometric
method for measuring serum thymidine kinase activity in
malignant lymphoma in dogs . Res. Vet. Sci. 80 , 17 – 24 .